Headache  >>  telcagepant (MK-0974)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
telcagepant (MK-0974) / Merck (MSD)
NCT00701389: Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)

Completed
1
24
NA
telcagepant potassium, sumatriptan, sumatriptan placebo, telcagepant potassium placebo
Merck Sharp & Dohme LLC
Migraine Disorders
04/08
04/08

Download Options